{"id":9414,"date":"2021-04-26T09:56:43","date_gmt":"2021-04-26T16:56:43","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=9414"},"modified":"2021-04-28T09:57:24","modified_gmt":"2021-04-28T16:57:24","slug":"bnt162b2-vaccination-effectively-prevents-the-rapid-rise-of-sars-cov-2-variant-b-1-1-7-in-high-risk-populations-in-israel","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/26\/bnt162b2-vaccination-effectively-prevents-the-rapid-rise-of-sars-cov-2-variant-b-1-1-7-in-high-risk-populations-in-israel\/","title":{"rendered":"BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in High Risk Populations in Israel"},"content":{"rendered":"<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">The SARS-CoV-2 B.1.1.7 variant was 45% more transmissible than the original strain in Israel, and was identified in more than 90% of positive tests by February 4<\/span><span style=\"font-weight: 400\">th<\/span><span style=\"font-weight: 400\">, according to an analysis of nearly 300,000 RT-PCR samples collected between December 6, 2020 and February 10, 2021. The authors note that surveillance programs and prioritized vaccination, which initially focused on the elderly population, quickly prevented B.1.1.7-associated infections among this group. The study found a sharp decline in cases when ~50% of older adults were two weeks post-receipt of their first dose, at a time when the B.1.1.7 variant gained transmission dominance among those aged 0-59.<\/span><\/li>\n<\/ul>\n<p><i><span style=\"font-weight: 400\">Munitz et al.\u00a0(Apr 2021). BNT162b2 Vaccination Effectively Prevents the Rapid Rise of SARS-CoV-2 Variant B.1.1.7 in High Risk Populations in Israel. Cell Reports Medicine. <\/span><\/i><a href=\"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100264\"><span style=\"font-weight: 400\">https:\/\/doi.org\/10.1016\/j.xcrm.2021.100264<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The SARS-CoV-2 B.1.1.7 variant was 45% more transmissible than the original strain in Israel, and was identified in more than 90% of positive tests by February 4th, according to an analysis of nearly 300,000 RT-PCR samples collected between December 6, 2020 and February 10, 2021. The authors note that surveillance programs and prioritized vaccination, which&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2021\/04\/26\/bnt162b2-vaccination-effectively-prevents-the-rapid-rise-of-sars-cov-2-variant-b-1-1-7-in-high-risk-populations-in-israel\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[147],"topic":[31],"class_list":["post-9414","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-vaccination","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=9414"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9414\/revisions"}],"predecessor-version":[{"id":9415,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/9414\/revisions\/9415"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=9414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=9414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=9414"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=9414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}